-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Liafensine in Treatment Resistant Depression
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Liafensine in Treatment Resistant Depression report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Liafensine in Treatment Resistant Depression Drug Details: Liafensine (DB-104) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vosaroxin in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vosaroxin in Refractory Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vosaroxin in Refractory Acute Myeloid Leukemia Drug Details: Vosaroxin...
-
Product Insights
NewVascular Concepts Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Vascular Concepts Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Vascular Concepts Ltd (Vascular Concepts), formerly Medical Concepts Ltd, a subsidiary of Sahajanand Medical Technologies Pvt Ltd, designs, develops, manufactures and markets endovascular medical devices for the treatment of arterial diseases. Its product range includes structural heart devices, coronary and peripheral stents. The company also offers percutaneous transluminal coronary angioplasty (PTCA) and thrombus aspiration catheters. Vascular Concepts is developing...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DB-108 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DB-108 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DB-108 in Non-Small Cell Lung Cancer Drug Details: DB-108 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mesothelin-CAR-T Cell Immunotherapy in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mesothelin-CAR-T Cell Immunotherapy in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mesothelin-CAR-T Cell Immunotherapy in Pancreatic Cancer Drug Details: The...
-
Product Insights
PTCA Drug Coated Balloon (DCB) Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Report Overview A Drug Coated Balloon (DCB) Catheter is an anti-restenotic drug coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries. The PTCA Drug Coated Balloon (DCB) Catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed...
-
Product Insights
NewTreatment Resistant Depression – Drugs In Development, 2024
Empower your strategies with our Treatment Resistant Depression – Drugs In Development, 2024 report and make more profitable business decisions. Treatment-resistant depression (TRD) refers to a form of depression that does not adequately respond to standard treatments, such as antidepressant medications or psychotherapy, even after multiple trials of different therapies. It can be a challenging and distressing condition for individuals experiencing persistent depressive symptoms. Some common characteristics of treatment-resistant depression include inadequate response to antidepressants; persistent symptoms, which can include feelings...
-
Product Insights
NewHigh-Grade Glioma – Drugs In Development, 2024
Empower your strategies with our High-Grade Glioma – Drugs In Development, 2024 report and make more profitable business decisions. High-grade gliomas (HGGs) are tumors of the central nervous system that arise from mutated cells of the brain and spinal cord. Symptoms include developmental delay, headaches, backaches, nausea and vomiting, dizziness, gait disturbances, impaired vision, lack of concentration, drowsiness, sleep disturbances, dysregulated appetite, paralysis, and seizures. Treatment includes chemotherapy and radiation therapy. The High-Grade Glioma drugs in development market research report provide...
-
Product Insights
NewSchizophrenia – Drugs In Development, 2024
Empower your strategies with our Schizophrenia – Drugs In Development, 2024 report and make more profitable business decisions. Schizophrenia is a chronic, severe, and disabling brain disorder that generally appears in late adolescence or early adulthood. Symptoms include delusions, hallucinations, disorganized speech, and disorganized behavior. Risk factors include family history, age, drugs (psychoactive), and weakened immune system. Treatment includes antipsychotic medications. The Schizophrenia drugs in development market research report provide comprehensive information on the therapeutics under development for Schizophrenia, complete with...
-
Product Insights
NewBlood Glucose Meters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Blood Glucose Meters Pipeline Market Report Overview A blood glucose meter is an electronic diabetic management device used for measuring blood glucose levels. Additionally, continuous glucose monitors are covered under this segment. The blood glucose meters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials,...